Heart and blood vessels

Cardiovascular diseases are one of the most common causes of death in Lithuania, from which about 4 million people die every year in Europe. People. In Lithuania, in a group of people who have reached the age of 45, cardiovascular diseases become the most common cause of morbidity and mortality.

Cardiovascular diseases are the leading cause of death both in Lithuania and in Europe. In Lithuania, over the past decade, the death rate from cardiovascular diseases has reached a threshold three times the average in the European Union. Diseases belonging to this group are diagnosed at an increasingly young age.

The patient’s own involvement in the management of risk factors for these diseases is crucial. Some of the major risk factors for cardiovascular disease may not be perceived or known to the patient. As more and more young people suffer acute myocardial infarction or stroke, both preventive measures and innovative treatments can help prevent them – it’s important to seek help in time.

Cardiovascular treatment solutions:

CORONARY ARTERY DISEASE

DEEP VEIN THROMBOSIS

AORTIC ANEURYSM

Accurate diagnosis, a personalised, patient-specific treatment approach and continuous monitoring are essential to prolong patients’ life expectancy. Innovative, patient-friendly, integrated cardiovascular treatment solutions help professionals in the health sector to achieve their goals, deliver results and innovate.

Let's get in touch

Do you have any questions or want to know more about our solutions? Write it and soon our expert will contact you.

Products

3

CAS-One IR

Artificial intelligence navigation system developed by Swiss manufacturer CASCINATION to help plan, navigate and remove tumours during percutaneous interventions

1

TATO

An attachment developed by Japanese manufacturer TERUMO that can use up to four antennas simultaneously. It is extremely easy to operate, ergonomic and ensures a safe procedure

2

CRYOCARE TOUCH

US company VARIAN's system is designed to freeze tissue at ultra-low temperatures, and the cryoprobe can produce "ice balls" of various sizes

4

CLINIPORATION VITAE

The IGEA system from IGEA, an Italian company, is an electrochemotherapy system that can be used for both superficial tumours and parenchymal tumours